major-depressive-disorder

Documents about major-depressive-disorder

• Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder#848460ClinicalTrials.gov
• Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder#865937ClinicalTrials.gov
• The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.#871304ClinicalTrials.gov
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)#871990ClinicalTrials.gov
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors#881638ClinicalTrials.gov
• The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder#980920ClinicalTrials.gov
• Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms#856585ClinicalTrials.gov
• Ketogenic Diet for Depression#994043ClinicalTrials.gov
• New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)#910345ClinicalTrials.gov
• Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder#993267ClinicalTrials.gov
• Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder#835901ClinicalTrials.gov
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)#914100ClinicalTrials.gov
• Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients#180219ClinicalTrials.gov
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder#827158ClinicalTrials.gov
• Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response#834364ClinicalTrials.gov
• Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)#839482ClinicalTrials.gov
• Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)#847658ClinicalTrials.gov
• Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder#852779ClinicalTrials.gov
• Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder#862120ClinicalTrials.gov
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder#865279ClinicalTrials.gov
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder#870503ClinicalTrials.gov
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder#883539ClinicalTrials.gov
• A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder#908646ClinicalTrials.gov
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.#909073ClinicalTrials.gov
• Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder#966290ClinicalTrials.gov
• Shortened LSD Intervention for Major Depressive Disorder#907256ClinicalTrials.gov
• Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation#864966ClinicalTrials.gov
• Brain Imaging, Genetics and Treatment for Major Depression#847301ClinicalTrials.gov
• Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study#812968ClinicalTrials.gov
• Neurocognition and Work Productivity in Major Depressive Disorder (MDD)#825067ClinicalTrials.gov
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder#852705ClinicalTrials.gov
• Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)#855251ClinicalTrials.gov
• Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder#868985ClinicalTrials.gov
• Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder#876763ClinicalTrials.gov
• A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder#880172ClinicalTrials.gov
• Measurement-Based Care Vs. Standard Care for Major Depressive Disorder#886000ClinicalTrials.gov
• Pilot Study of Open-label Placebo to Treat Major Depressive Disorder#889512ClinicalTrials.gov
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)#889571ClinicalTrials.gov
• Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder#893489ClinicalTrials.gov
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)#902744ClinicalTrials.gov
• Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder#906047ClinicalTrials.gov
• Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder#908455ClinicalTrials.gov
• Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment#969063ClinicalTrials.gov
• A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder#993596ClinicalTrials.gov
• Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder#993745ClinicalTrials.gov
• A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder#825662ClinicalTrials.gov
• Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder#915218ClinicalTrials.gov
• Combined sleep deprivation and light therapy for depression in major depressive disorder and bipolar disorder#928104OSF
• qEEG Brain Signature of Depression & Neuromodulation-induced Recovery#852783ClinicalTrials.gov
• Hyperthermic Yoga for Depressive Symptoms#1009525ClinicalTrials.gov